CD47 and diffuse large B-cell lymphoma: Further studies on DLBCL cell lines (OCI-Ly3, U-2932, SU-DHL-2, SU-DHL-4, SU-DHL-6, SU-DHL-10) demonstrated increased therapeutic effect of RTX after blocking CD47 in non-GCB DLBCL model [84].